CCL2 and metabolic dysfunction-associated steatohepatitis: In order to address the clinical relevance of GILZ–CCL2 axis in human LF, we analyzed GILZ mRNA expression in RNAseq data obtained from NASH and NAFLD patient liver samples63,64.